Amir Genosar

President & CEO at Aktivax


Amir is an accomplished serial entrepreneur and inventor in the drug delivery device space. To date, Amir has formed a number of medical startup companies and served in a variety of roles for these companies including CEO, CTO, and serving on the board of directors. In 2006, Amir co-founded SteadyMed (acquired by United Therapeutics for $216 million in 2018), and was an inventor of its drug-device combination product patch pump. Along his professional career Amir helped several leading healthcare companies innovate and address unmet needs in the drug delivery device space including, Johnson & Johnson, Novartis, Phillips, and Medtronic. He is an inventor of the MAP Pharmaceutical combination product inhaler technology (acquired by Allergan for $958 million in 2013). Prior to his innovation and entrepreneurship career Amir held manufacturing positions for drug delivery devices.

Amir is passionate about building a holistic approach to care for the communities that Aktiv Pharma Group’s products serve. In his view, the foundation of the success of this approach is a company culture that emphasizes care of and passion for the Aktiv team, and appreciation of the opportunity to engage with each individual’s talents, gifts, and personal journey.

Amir is a father to four strong young women with whom he loves exploring the outdoors including hiking, backpacking, camping, skiing, surfing, long road trips, and other world class adventures.


View in org chart


  • President & CEO

    Current role

View in org chart

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.